- Home
- SVRE vs LSBPW Comparison
SVRE vs LSBPW Comparison
Compare SVRE & LSBPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRE
- LSBPW
- Stock Information
- Founded
- SVRE 2014
- LSBPW N/A
- Country
- SVRE Israel
- LSBPW China
- Employees
- SVRE N/A
- LSBPW 758
- Industry
- SVRE
- LSBPW Biotechnology: Pharmaceutical Preparations
- Sector
- SVRE
- LSBPW Health Care
- Exchange
- SVRE Nasdaq
- LSBPW Nasdaq
- Market Cap
- SVRE 2.6M
- LSBPW N/A
- IPO Year
- SVRE 2022
- LSBPW N/A
- Fundamental
- Price
- SVRE $0.12
- LSBPW $0.07
- Analyst Decision
- SVRE
- LSBPW
- Analyst Count
- SVRE 0
- LSBPW 0
- Target Price
- SVRE N/A
- LSBPW N/A
- AVG Volume (30 Days)
- SVRE 5.3M
- LSBPW N/A
- Earning Date
- SVRE 08-27-2024
- LSBPW N/A
- Dividend Yield
- SVRE N/A
- LSBPW N/A
- EPS Growth
- SVRE N/A
- LSBPW N/A
- EPS
- SVRE N/A
- LSBPW N/A
- Revenue
- SVRE $458,952.00
- LSBPW N/A
- Revenue This Year
- SVRE N/A
- LSBPW N/A
- Revenue Next Year
- SVRE $422.52
- LSBPW N/A
- P/E Ratio
- SVRE N/A
- LSBPW N/A
- Revenue Growth
- SVRE N/A
- LSBPW N/A
- 52 Week Low
- SVRE $0.11
- LSBPW N/A
- 52 Week High
- SVRE $1.50
- LSBPW N/A
- Technical
- Relative Strength Index (RSI)
- SVRE 29.85
- LSBPW N/A
- Support Level
- SVRE $0.11
- LSBPW N/A
- Resistance Level
- SVRE $0.13
- LSBPW N/A
- Average True Range (ATR)
- SVRE 0.01
- LSBPW 0.00
- MACD
- SVRE 0.00
- LSBPW 0.00
- Stochastic Oscillator
- SVRE 24.14
- LSBPW 0.00
About SVRE SaverOne 2014 Ltd.
Saverone 2014 Ltd provides driver protection solutions. The company develops and deploys ADAS technologies for transportation safety and driver assistance. The company's product restricts the driver from surfing, communicating, and receiving alerts while driving. The Company has developed a system that provides a solution to the problem of distracted driving caused by cell phone use, which endangers the driver, passengers, other drivers on the road, and pedestrians.
About LSBPW LakeShore Biopharma Co. Ltd
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.